Recovering Unpaid Medical Equipment Milestones, 'Reagent-Rental' Minimum Shortfalls & Hospital CMC/AMC Invoices

India's healthcare infrastructure boom has driven unprecedented demand for advanced diagnostic imaging, critical care ventilators, surgical suites, and automated In-Vitro Diagnostic (IVD) pathology platforms. However, behind glossy corporate hospital lobbies and bustling diagnostic chains lies a systemic institutional receivables bottleneck. Medical equipment Original Equipment Manufacturers (OEMs), authorized tier-1 distributors, and biomedical engineering maintenance firms routinely suffer devastating liquidity freezes resulting from calculated buyer default strategies.

Hospital managements and private diagnostic centers exploit standard commercial contracting ambiguities across three primary deployment structures:

• The Withheld FAT Milestone (Capital Systems): For high-ticket CT scanners (₹1.5Cr–₹4.5Cr), 1.5T/3.0T MRI units (₹4Cr–₹10Cr), and digital Cath Labs, contracts typically specify a 30% advance, 60% on delivery/site readiness, and a final 10%–20% upon signing the Final Acceptance Test (FAT) certificate. Hospitals routinely pay the delivery milestone, start scanning paying clinical patients on day one, but indefinitely withhold the final ₹25L–₹1.5Cr FAT sign-off, fabricating frivolous software calibration or environmental chill complaints.
• The IVD 'Reagent-Rental' Piracy Trap: Diagnostic centers procure advanced automated clinical chemistry or chemiluminescence immunoassay analyzers (worth ₹20L–₹50L) without paying any capital equipment fee, entering a 5-year binding commitment to purchase a Minimum Monthly Guarantee (MMG) of proprietary test kits. Within 6–9 months, labs breach their volume commitments, hack the reagent RFID or barcode locks, and feed cheap unauthorized grey-market reagents into the machine, leaving the OEM with unamortized capital exposure and unpaid consumable shortfalls.
• Biomedical AMC/CMC & Spare Parts Default: Hospitals contract biomedical maintenance contractors for Annual Maintenance Contracts (AMC) and Comprehensive Maintenance Contracts (CMC) covering critical ICU equipment (ventilators, defibrillators, anesthesia workstations). When quarterly maintenance bills age past 180 days, hospitals withhold payment yet threaten engineers with criminal negligence under criminal law if they withdraw servicing or retrieve proprietary PCB circuit boards.

Compounding this crisis is the acute regulatory exposure surrounding imaging machinery. Uninformed vendors attempting self-help repossession of unpaid ultrasound machines face non-bailable criminal FIRs under the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, 1994. Recovering MedTech receivables requires a sophisticated convergence of the Sale of Goods Act, 1930, the MSMED Act, 2006, the Commercial Courts Act, 2015, and strict healthcare statutory protocols.

In the In-Vitro Diagnostics (IVD) industry, 'Reagent-Rental' (also termed Placement or Cost-Per-Test / CPT) is the dominant commercial model. A diagnostic chain or corporate hospital takes a high-throughput fully automated analyzer—such as a clinical chemistry analyzer, 5-part hematology counter, or chemiluminescence immunoassay (CLIA) platform valued between ₹20 Lakhs and ₹60 Lakhs—at zero capital expenditure. In exchange, the lab executes a binding 3-to-5 year contract committing to purchase a guaranteed minimum monthly volume of proprietary reagents, calibrators, and quality-control packs exclusively from the OEM or its authorized distributor.

Enforcing Reservation of Title & Liquidated Shortfall Damages

Under Indian law, the OEM is fully protected by two powerful statutory levers:

1. Bailment & Retention of Title (Sale of Goods Act Section 25 & Contract Act Section 148): The placement agreement is a contract of bailment coupled with conditional supply. Title to the analyzer never passes to the lab. Loading unauthorized consumables constitutes misuse of bailed property under Section 153 and Section 154 of the Indian Contract Act, 1872, rendering the contract voidable at the option of the OEM and entitling the supplier to immediate repossession.
2. Accelerated Minimum Guarantee Shortfalls (Contract Act Section 74): Well-drafted placement agreements provide that upon default or unapproved kit usage, the OEM may terminate the arrangement and accelerate the entire unamortized capital cost of the analyzer alongside accrued MMG shortfalls as pre-estimated genuine liquidated damages under Section 74 (Kailash Nath Associates v. DDA).
3. Section 9 Commercial Injunctions: Because running pirated reagents voids regulatory IVD performance standards and damages sensitive optical flow-cells, OEMs can obtain urgent ad-interim injunctions from Commercial Courts under Section 9 of the Arbitration Act restraining the laboratory from loading non-OEM consumables.

Where the diagnostic center owes more than 45 days of reagent invoices, suppliers registered under Udyam should simultaneously invoke Section 18 of the MSMED Act, 2006 to demand 3x RBI compound interest and trigger Section 43B(h) income tax disallowance against the lab.

The single most dangerous legal trap in Indian medical equipment recovery occurs when an OEM, financier, or dealer attempts to repossess a defaulted Ultrasound machine or Color Doppler imaging system. Unlike standard commercial assets (such as CNC machines or commercial vehicles), ultrasound machines are classified as regulated reproductive diagnostic devices under the Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994 (PCPNDT Act).

The 4-Step Bulletproof PCPNDT Repossession SOP

To lawfully repossess a defaulted ultrasound unit without violating PCPNDT criminal provisions, MedTech creditors must execute this mandatory advocate-vetted protocol:

When selling multi-crore imaging assets—such as 64-slice/128-slice CT systems, 1.5T/3.0T MRI scanners, and flat-panel digital Cath Labs—procurement agreements typically structure payments in milestones: 20% advance with purchase order, 70% against dispatch/delivery challan, and 10% on Final Acceptance Test (FAT) or clinical application handover.

A ubiquitous industry abuse occurs where the hospital pays the delivery tranche, hooks the scanner to its Picture Archiving and Communication System (PACS), and begins scanning 30 to 60 paying clinical patients every single day. Yet, when the OEM demands the final 10% milestone (often ₹30L to ₹1 Crore), the hospital management refuses to sign the FAT sign-off document, citing unsubstantiated complaints regarding application software, chiller temperatures, or image noise.

Dismantling Bad-Faith FAT Defenses under Section 42 Sale of Goods Act

Indian contract law provides a definitive answer to bad-faith FAT withholding:

• Statutory Deemed Acceptance (Section 42, Sale of Goods Act 1930):The Supreme Court and High Courts have consistently held that when a buyer utilizes machinery commercially for profit or revenue generation, that commercial exploitation constitutes an "act inconsistent with the ownership of the seller." By operation of Section 42, the hospital is deemed in law to have accepted the equipment. The hospital loses its right to reject the goods or withhold milestone payments.
• Order XXXVII CPC Summary Suit: Because the delivery is admitted, installation is evidenced by AERB (Atomic Energy Regulatory Board) operational licenses, and commercial patient scanning is recorded on PACS, the supplier can file a Summary Suit under Order XXXVII of the CPC. The hospital has no bona fide defense and must deposit the contested milestone amount into court as a condition for leave to defend.
• MSMED Section 16 Interest Acceleration: For Udyam-registered suppliers, the 45-day statutory payment clock commences on the date of deemed acceptance. Under Section 16, interest accrues at 3x the RBI Bank Rate compounded monthly, transforming a withheld ₹50L milestone into an untenable financial liability for the defaulting hospital.

Biomedical engineering maintenance organizations and third-party Multi-Vendor Service (MVS) contractors keep hospital ICU ventilators, dialysis units, patient monitors, and surgical electrosurgical units functioning 24x7. However, hospitals routinely place AMC/CMC and emergency spare parts bills at the bottom of their accounts payable hierarchy, accumulating 12 to 24 months of unpaid quarterly invoices.

The Medico-Legal Safe-Harbor Protocol for Suspending AMC Support

Service firms are not indentured laborers. Under Section 39 of the Indian Contract Act, 1872, persistent non-payment of maintenance retainers constitutes fundamental contractual repudiation. To insulate engineers from negligence claims while forcing immediate settlement, contractors must adopt the following protocol:

1. 30-Day Cure-or-Suspend Statutory Legal Notice: Serve an Advocate Legal Notice itemizing all unpaid quarterly invoices and installed spare parts, granting 30 calendar days to cure arrears.
2. Statutory Administrative Disclosure: Concurrently serve copies of the notice on the District Chief Medical Officer (CMO), the State Directorate of Health Services, and the State Clinical Establishments Authority, formally placing the administrative onus of patient safety squarely upon hospital leadership.
3. Software & Dongle Licensing Deactivation: For remote telematics, cloud diagnostics, or software-enabled diagnostic keys, formally terminate remote licenses in strict accordance with software end-user license agreements (EULA).
4. MSME Samadhaan Filing: File an immediate Section 18 reference before the MSEFC claiming all outstanding AMC/CMC invoices plus 3x RBI compound interest and replacement component costs.